← All public profiles

eDIS-ICU: Electronic Delirium Screening Tool for the ICU

2021

A purpose-designed ICU screening app intended to support efficient delirium case-finding without specialist expertise. Promising pilot accuracy requires confirmation in a definitive, larger validation study.

At a glance

Purpose
Episodic assessment
Population
Adult
Setting
Intensive care
Time
designed for efficient app-guided screening; exact completion time not reported
Score or threshold
App classification of probable delirium; use the authorised app or publication for the full algorithm

Format: eDIS-ICU guides the assessor through an app-based workflow and returns a probable-delirium classification. The exact prompts, item count, timing and algorithm should be obtained from the developers or publication rather than reconstructed from this page.

Primary validation papers

1 identified diagnostic-accuracy paper

Other forms of validation are described in the evidence section. What is counted?

Large-scale clinical implementation

Not yet reviewed.

A focused implementation review has not yet been completed for this profile.

Training and instructions

Public training resources have not yet been confirmed in this review. Check the linked developer or original source for instructions.

Start here

Tool and original sources

This record describes a method rather than a downloadable bedside form. The main source is linked below.

Original paper

  • Original paperSutt AL, Flaws D, Gunn H, Eeles E, Lye I, Irvine L, et al. Screening for delirium in the intensive care unit using eDIS-ICU - A purpose-designed app: A pilot study. Australian critical care : official journal of the Confederation of Australian Critical Care Nurses. 2021;34(6):547-551. doi: 10.1016/j.aucc.2020.12.008. PMID: 33766486.

    This is the original published source for eDIS-ICU. It reported sensitivity of 85.7% and specificity of 72.7% against an independent DSM-5 clinical assessment.

One DTA study identifiedEmerging clinical record
Classification

Classification

A tool may belong to more than one category. Select a linked category to see other relevant profiles.

Evidence

Diagnostic-accuracy evidenceOne DTA study identified

Reported sensitivity and specificity

Headline metric source

Original/source study · 2021; pmid:33766486

Denominator
Reported source unit: 29 (analysis unit not fully reconciled)
Reference standard
Expert DSM-5 diagnosis
85.7%
Sensitivity
72.7%
Specificity

Earliest DTA evaluation identified in the current audit; see the linked source and methodological caveats.

More evidence and citation details
Full name
Electronic Delirium Screening Tool for the ICU
Also known as
eDIS ICU
Related profiles
eDIS-MED
Evidence summary
single-pilot-DTA
Diagnostic-accuracy evaluations
1
Reference standard
Expert DSM-5 diagnosis
Citation
Sutt AL, Flaws D, Gunn H, Eeles E, Lye I, Irvine L, Patterson S, Bagshaw T, O'Luanaigh C, Tronstad O, Fraser J Screening for delirium in the intensive care unit using eDIS-ICU - A purpose-designed app: A pilot study Australian critical care : official journal of the Confederation of Australian Critical Care Nurses. 2021;34(6):547-551. PMID 33766486

Primary validation studies

Distinct primary publications from the current diagnostic-accuracy audit. Reviews and repeated evaluations within one paper are not counted again. Overlapping cohorts have not all been reconciled. Read the counting rules and limitations.

Open 1 identified paper
  1. Sutt AL, Flaws D, Gunn H, Eeles E, Lye I, Irvine L, Patterson S, Bagshaw T, O'Luanaigh C, Tronstad O, Fraser J (2021). Screening for delirium in the intensive care unit using eDIS-ICU - A purpose-designed app: A pilot study. Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

    Reference category: independent clinical reference.

Copyright and reuse
Information checked
2026-07-19

Instrument-specific terms apply. See the access and copyright policy or send a correction.

Base clinical review: 2026-07-29. Instrument description source check: 2026-09-05. Scope and limitations.